Inspiremd Stock Filter Stocks by Fundamentals
NSPR Stock | USD 2.51 0.01 0.40% |
Fundamental analysis of InspireMD allows traders to better anticipate movements in InspireMD's stock price by examining its financial health and performance throughout various phases of its business cycle.
InspireMD | Shares Owned by Insiders | Build AI portfolio with InspireMD Stock |
InspireMD ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, InspireMD's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to InspireMD's managers, analysts, and investors.Environmental | Governance | Social |
InspireMD Institutional Holders
Institutional Holdings refers to the ownership stake in InspireMD that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of InspireMD's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing InspireMD's value.Shares | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 71.3 K | Northern Trust Corp | 2025-03-31 | 44.9 K | Schonfeld Strategic Advisors Llc | 2025-03-31 | 34.1 K | Renaissance Technologies Corp | 2025-03-31 | 31.4 K | Dana Investment Advisors Inc | 2025-03-31 | 30.1 K | Elias Asset Management Inc | 2025-03-31 | 30 K | Mesirow Fin Investmt Mgmt Intl Equity | 2025-03-31 | 30 K | Courier Capital Corp | 2025-03-31 | 30 K | Hollencrest Securities, Llc | 2025-03-31 | 20 K | Nantahala Capital Management, Llc | 2025-03-31 | 2.3 M | Rosalind Advisors, Inc. | 2025-03-31 | 2.3 M |
InspireMD Fundamentals
Return On Equity | -1.14 | ||||
Return On Asset | -0.58 | ||||
Operating Margin | (7.50) % | ||||
Current Valuation | 52.21 M | ||||
Shares Outstanding | 30.64 M | ||||
Shares Owned By Insiders | 29.94 % | ||||
Shares Owned By Institutions | 42.29 % | ||||
Number Of Shares Shorted | 320.68 K | ||||
Price To Earning | (0.16) X | ||||
Price To Book | 2.68 X | ||||
Price To Sales | 10.81 X | ||||
Revenue | 7.01 M | ||||
Gross Profit | 1.51 M | ||||
EBITDA | (33.22 M) | ||||
Net Income | (32.01 M) | ||||
Cash And Equivalents | 26.47 M | ||||
Cash Per Share | 3.18 X | ||||
Total Debt | 2.34 M | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 6.26 X | ||||
Book Value Per Share | 0.95 X | ||||
Cash Flow From Operations | (21.87 M) | ||||
Short Ratio | 0.92 X | ||||
Earnings Per Share | (0.77) X | ||||
Target Price | 4.5 | ||||
Number Of Employees | 66 | ||||
Beta | 0.57 | ||||
Market Capitalization | 75.98 M | ||||
Total Asset | 46.81 M | ||||
Retained Earnings | (253.51 M) | ||||
Working Capital | 32.84 M | ||||
Current Asset | 4.63 M | ||||
Current Liabilities | 6.83 M | ||||
Net Asset | 46.81 M |
About InspireMD Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InspireMD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InspireMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InspireMD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.